Engineered CRISPR-Cas9 nucleases with altered PAM specificities
Kleinstiver et al. (2015). Nat Biotechnol|
DOI: 10.1038/nbt.3404|
Citations: 644
Key findings
-
01
Developed KKH-SaCas9 variant with relaxed PAM (NNNRRT vs NNGRRT). Expanded targetable sites by ~2-fold while maintaining efficiency and specificity.